Operating Income Summary of Medicamen Biotech Limited

Medicamen Biotech Limited's latest annual operating income in 2023 was - INR , down -16.98% from previous year.
Medicamen Biotech Limited's latest quarterly operating income in 2024 Q1 was 16.75 Million INR , down -57.86% from previous quarter.
Medicamen Biotech Limited reported an annual operating income of 182.46 Million INR in 2022, down -2.46% from previous year.
Medicamen Biotech Limited reported an annual operating income of 187.06 Million INR in 2021, up 6.92% from previous year.
Medicamen Biotech Limited reported a quarterly operating income of 151.47 Million INR for 2023 FY, down -16.98% from previous quarter.
Medicamen Biotech Limited reported a quarterly operating income of 52.6 Million INR for 2023 Q1, up 8.1% from previous quarter.

Annual Operating Income Chart of Medicamen Biotech Limited (2023 - 2007)

Historical Annual Operating Income of Medicamen Biotech Limited (2023 - 2007)

Year	Operating Income	Operating Income Growth
2023	- INR	-16.98%
2022	182.46 Million INR	-2.46%
2021	187.06 Million INR	6.92%
2020	174.95 Million INR	0.41%
2019	174.25 Million INR	12.69%
2018	154.63 Million INR	4.92%
2017	147.38 Million INR	131.91%
2016	63.55 Million INR	792.86%
2015	7.11 Million INR	505.35%
2014	1.17 Million INR	-34.21%
2013	1.78 Million INR	103.67%
2012	-48.75 Million INR	-643.88%
2011	-6.55 Million INR	-115.56%
2010	42.13 Million INR	-28.65%
2009	59.05 Million INR	236.72%
2008	17.53 Million INR	-6.54%
2007	18.76 Million INR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	16.75 Million INR	-57.86%
2023 FY	151.47 Million INR	-16.98%
2023 Q1	52.6 Million INR	8.1%
2023 Q2	28.21 Million INR	-46.36%
2023 Q3	39.18 Million INR	38.87%
2023 Q4	39.76 Million INR	1.47%
2022 FY	182.46 Million INR	-2.46%
2022 Q4	48.66 Million INR	13.81%
2022 Q3	42.75 Million INR	1.01%
2022 Q2	42.33 Million INR	2.5%
2022 Q1	41.29 Million INR	19.87%
2021 Q2	48.76 Million INR	3.51%
2021 FY	187.06 Million INR	6.92%
2021 Q3	47.41 Million INR	-2.77%
2021 Q1	47.11 Million INR	20.07%
2021 Q4	34.45 Million INR	-27.34%
2020 Q1	34.77 Million INR	2.74%
2020 Q2	49.77 Million INR	43.14%
2020 Q3	45.41 Million INR	-8.77%
2020 Q4	39.23 Million INR	-13.6%
2020 FY	174.95 Million INR	0.41%
2019 FY	174.25 Million INR	12.69%
2019 Q2	54.32 Million INR	21.23%
2019 Q3	52.49 Million INR	-3.38%
2019 Q1	44.81 Million INR	6.54%
2019 Q4	33.84 Million INR	-35.52%
2018 Q4	42.06 Million INR	9.0%
2018 Q2	54.6 Million INR	11.5%
2018 FY	154.63 Million INR	4.92%
2018 Q1	48.97 Million INR	14.38%
2018 Q3	38.59 Million INR	-29.33%
2017 Q2	33.64 Million INR	7.35%
2017 Q3	34.06 Million INR	1.26%
2017 Q4	42.81 Million INR	25.69%
2017 FY	147.38 Million INR	131.91%
2017 Q1	31.34 Million INR	98.78%
2016 Q1	14.22 Million INR	-34.24%
2016 FY	63.55 Million INR	792.86%
2016 Q4	15.76 Million INR	-17.24%
2016 Q2	14.55 Million INR	2.32%
2016 Q3	19.05 Million INR	30.93%
2015 FY	7.11 Million INR	505.35%
2015 Q3	-15.1 Million INR	-571.12%
2015 Q4	21.62 Million INR	243.17%
2015 Q2	3.2 Million INR	222.93%
2015 Q1	-2.6 Million INR	-10.55%
2014 Q4	-2.35 Million INR	44.04%
2014 Q1	1.63 Million INR	132.94%
2014 Q2	6.11 Million INR	274.24%
2014 FY	1.17 Million INR	-34.21%
2014 Q3	-4.21 Million INR	-168.95%
2013 Q3	-5.2 Million INR	-170.51%
2013 Q2	7.37 Million INR	61.4%
2013 Q4	-4.96 Million INR	4.66%
2013 FY	1.78 Million INR	103.67%
2013 Q1	4.57 Million INR	135.08%
2012 Q2	-11.87 Million INR	-60.3%
2012 Q4	-13.03 Million INR	20.73%
2012 FY	-48.75 Million INR	-643.88%
2012 Q1	-7.4 Million INR	-129.87%
2012 Q3	-16.44 Million INR	-38.44%
2011 Q4	24.79 Million INR	369.88%
2011 FY	-6.55 Million INR	-115.56%
2011 Q2	-22.16 Million INR	0.0%
2011 Q3	-9.18 Million INR	58.54%
2010 FY	42.13 Million INR	-28.65%
2009 FY	59.05 Million INR	236.72%
2008 FY	17.53 Million INR	-6.54%
2008 Q4	-6.41 Million INR	0.0%
2007 FY	18.76 Million INR	0.0%
2007 Q4	8 Million INR	0.0%

Peer Operating Income Comparison of Medicamen Biotech Limited

Name	Operating Income	Operating Income Difference
Alembic Pharmaceuticals Limited	5.75 Billion INR	100.0%
Aurobindo Pharma Limited	42.2 Billion INR	100.0%
Glenmark Life Sciences Limited	8.97 Billion INR	100.0%
Granules India Limited	6.81 Billion INR	100.0%
Indoco Remedies Limited	1.29 Billion INR	100.0%
Achyut Healthcare Limited	4.43 Million INR	100.0%
Ajanta Pharma Limited	19.67 Billion INR	100.0%
Alkem Laboratories Limited	19.46 Billion INR	100.0%
Alpa Laboratories Limited	184.49 Million INR	100.0%
Brooks Laboratories Limited	14.44 Million INR	100.0%
AstraZeneca Pharma India Limited	1.71 Billion INR	100.0%
Bajaj HealthCare Limited	- INR	NaN%
Bliss GVS Pharma Limited	1.23 Billion INR	100.0%
Dr. Reddy's Laboratories Limited	67.72 Billion INR	100.0%
Eris Lifesciences Limited	5.18 Billion INR	100.0%
FDC Limited	2.98 Billion INR	100.0%
Glenmark Pharmaceuticals Limited	6.5 Billion INR	100.0%
Gufic Biosciences Limited	1.32 Billion INR	100.0%
Ind-Swift Laboratories Limited	4.42 Billion INR	100.0%
Ipca Laboratories Limited	7.98 Billion INR	100.0%
Jagsonpal Pharmaceuticals Limited	508.13 Million INR	100.0%
Krebs Biochemicals & Industries Limited	-151.95 Million INR	100.0%
Lasa Supergenerics Limited	-458 Million INR	100.0%
Laurus Labs Limited	3.94 Billion INR	100.0%
Lupin Limited	28.04 Billion INR	100.0%
Mankind Pharma Limited	21.51 Billion INR	100.0%
Medico Remedies Limited	100.3 Million INR	100.0%
Megasoft Limited	-121.1 Million INR	100.0%
NATCO Pharma Limited	25.96 Billion INR	100.0%
Piramal Pharma Limited	4.55 Billion INR	100.0%
RPG Life Sciences Limited	2.29 Billion INR	100.0%
Sigachi Industries Limited	1.47 Billion INR	100.0%
Sun Pharmaceutical Industries Limited	104.3 Billion INR	100.0%
Suven Pharmaceuticals Limited	4.6 Billion INR	100.0%
Syncom Formulations (India) Limited	249.25 Million INR	100.0%
Unichem Laboratories Limited	- INR	NaN%
Wanbury Limited	569.71 Million INR	100.0%
Windlas Biotech Limited	1.29 Billion INR	100.0%
ZIM Laboratories Limited	253.82 Million INR	100.0%
Zydus Lifesciences Limited	43.1 Billion INR	100.0%
Sun Pharma Advanced Research Company Limited	-4.11 Billion INR	100.0%
Divi's Laboratories Limited	33.08 Billion INR	100.0%
Hester Biosciences Limited	364.81 Million INR	100.0%
Procter & Gamble Health Limited	2.78 Billion INR	100.0%
Amrutanjan Health Care Limited	457.54 Million INR	100.0%
Bal Pharma Limited	233.9 Million INR	100.0%
Strides Pharma Science Limited	5.22 Billion INR	100.0%
Venus Remedies Limited	534.65 Million INR	100.0%
Aarti Pharmalabs Limited	3.12 Billion INR	100.0%
Nectar Lifesciences Limited	923.8 Million INR	100.0%
Shilpa Medicare Limited	1.36 Billion INR	100.0%
Aarti Drugs Limited	7.14 Billion INR	100.0%
IOL Chemicals and Pharmaceuticals Limited	1.59 Billion INR	100.0%
Suven Life Sciences Limited	-1.22 Billion INR	100.0%
Ind-Swift Limited	1.22 Billion INR	100.0%
Valiant Laboratories Limited	- INR	NaN%
J. B. Chemicals & Pharmaceuticals Limited	14.28 Billion INR	100.0%
Solara Active Pharma Sciences Limited	-3.85 Billion INR	100.0%
Themis Medicare Limited	392.58 Million INR	100.0%
Hikal Limited	32.11 Million INR	100.0%
Torrent Pharmaceuticals Limited	25.33 Billion INR	100.0%
Sequent Scientific Limited	- INR	NaN%
Novartis India Limited	626.5 Million INR	100.0%
Wockhardt Limited	-670 Million INR	100.0%
Jubilant Pharmova Limited	5.18 Billion INR	100.0%
Biofil Chemicals and Pharmaceuticals Limited	9.06 Million INR	100.0%
Neuland Laboratories Limited	5.31 Billion INR	100.0%
Morepen Laboratories Limited	4.17 Billion INR	100.0%
Kilitch Drugs (India) Limited	208.05 Million INR	100.0%
Mangalam Drugs & Organics Limited	27.45 Million INR	100.0%

Global Stocks Search

Medicamen Biotech Limited (MEDICAMEQ.BO)

Operating Income Summary of Medicamen Biotech Limited

Annual Operating Income Chart of Medicamen Biotech Limited (2023 - 2007)

Historical Annual Operating Income of Medicamen Biotech Limited (2023 - 2007)

Peer Operating Income Comparison of Medicamen Biotech Limited